Suppr超能文献

对同种异体肾移植具有天然耐受性的人类受者接种流感疫苗后的体液和细胞反应。

Humoral and cellular responses to influenza vaccination in human recipients naturally tolerant to a kidney allograft.

作者信息

Ballet C, Roussey-Kesler G, Aubin J-T, Brouard S, Giral M, Miqueu P, Louis S, van der Werf S, Soulillou J-P

机构信息

Institut National de la Santé et de la Recherche Médicale (I.N.S.E.R.M.), Unité 643: Immunointervention dans les Allo et xenotransplantations CHU-HOTEL DIEU, 30 Bd Jean Monnet, 44035 Nantes Cedex 01, France.

出版信息

Am J Transplant. 2006 Nov;6(11):2796-801. doi: 10.1111/j.1600-6143.2006.01533.x.

Abstract

Rare kidney allograft recipients enjoy unaltered graft function years after interruption of their immunosuppressive treatment. To assess the extent to which this state of 'operational tolerance' (TOL) is specific to the graft and not the result of a global immunodeficiency, we analyzed the response of such patients following influenza vaccination. Hemagglutination inhibition titers and frequency of IFNgamma-secreting T cells were measured before 1 and 3 months after vaccination. The proportion of healthy volunteers (HV) responding to vaccine was significantly higher than that of immunosuppressed (IS) patients. Three 'TOL' patients presented a humoral response similar to that of HV, whereas the two others had a poor response, like the IS recipients. Although the small number of patients does not allow for definitive conclusions to be made, these data suggest that the status of tolerance may be heterogeneous, with some patients with a global immunodeficiency and others with an adapted response to vaccination.

摘要

罕见的肾移植受者在中断免疫抑制治疗数年之后,移植肾功能仍未改变。为评估这种“操作性耐受”(TOL)状态在多大程度上是移植所特有的,而非全身性免疫缺陷的结果,我们分析了此类患者在接种流感疫苗后的反应。在接种疫苗前以及接种后1个月和3个月测量了血凝抑制效价和分泌IFNγ的T细胞频率。健康志愿者(HV)对疫苗产生反应的比例显著高于免疫抑制(IS)患者。3例“TOL”患者呈现出与HV相似的体液反应,而另外2例则反应较差,类似于IS受者。尽管患者数量较少,无法得出确定性结论,但这些数据表明耐受状态可能是异质性的,一些患者存在全身性免疫缺陷,而另一些患者对疫苗接种有适应性反应。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验